Sign in

CIK 0001439222

  • Large accelerated filer

AGIOS PHARMACEUTICALS, INC.

Sign in to watch
Ticker
AGIO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 617-649-8600
Business address
88 SIDNEY STREET, CAMBRIDGE, MA, 02139
Former names
AGIOS PHARMACEUTICALS INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$371,112
in 2 filings, $371K under 10b5-1 plans

Net −$371,112. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Gheuens Sarah −$371K Chief Medical Officer sold 15% of stake

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2018-02-16 Alenson Carman Principal Accounting Officer Grant or award · Restricted stock units +2,800 2,800
2018-02-16 Alenson Carman Principal Accounting Officer Grant or award · Restricted stock units +2,370 2,370
2018-02-16 Hoerter Steven L. Chief Commercial Officer Grant or award · Stock option (right to buy) +33,000 33,000
2018-02-16 Hoerter Steven L. Chief Commercial Officer Grant or award · Restricted stock units +8,250 8,250
2018-02-16 Hirsch Andrew Chief Financial Officer Grant or award · Stock option (right to buy) +33,000 33,000
2018-02-16 Hirsch Andrew Chief Financial Officer Grant or award · Restricted stock units +8,250 8,250
2018-02-16 Bowden Christopher Chief Medical Officer Option exercise +2,000 $35.16 $70K 2,881
2018-02-16 Bowden Christopher Chief Medical Officer Sale −1,500 $77.51 $116K 1,381
2018-02-16 Bowden Christopher Chief Medical Officer Sale −500 $78.08 $39K 881
2018-02-16 Bowden Christopher Chief Medical Officer Option exercise · Stock option (right to buy) −2,000 105,000
2018-02-16 Bowden Christopher Chief Medical Officer Grant or award · Stock option (right to buy) +33,000 33,000
2018-02-16 Bowden Christopher Chief Medical Officer Grant or award · Restricted stock units +8,250 8,250
2018-02-16 Biller Scott Chief Scientific Officer Grant or award · Stock option (right to buy) +33,000 33,000
2018-02-16 Biller Scott Chief Scientific Officer Grant or award · Restricted stock units +8,250 8,250
2018-02-16 Schenkein David P Chief Executive Officer Grant or award · Stock option (right to buy) +97,500 97,500
2018-02-16 Schenkein David P Chief Executive Officer Grant or award · Restricted stock units +24,375 24,375
2018-02-05 Biller Scott Chief Scientific Officer Option exercise +64 $0.47 $30 53,123
2018-02-05 Biller Scott Chief Scientific Officer Option exercise +2,936 $9.05 $27K 56,059
2018-02-05 Biller Scott Chief Scientific Officer Sale −799 $74.89 $60K 55,260
2018-02-05 Biller Scott Chief Scientific Officer Sale −1,100 $75.70 $83K 54,160

Page 66 of 80 · 1,590 trades